VA Arlington의 유방암 임상 시험
유방암 관련 연구 47개가 Arlington 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
The Vanguard Study: Testing a New Way to Screen for Cancer
피험자 모집 중건강한 지원자 환영
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
- Inova Fair Oaks Hospital, Fairfax · 11마일 거리
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
피험자 모집 중3상
- Virginia Cancer Specialists, PC, Fairfax · 11마일 거리
A Study of PHST001 in Advanced Solid Tumors
피험자 모집 중1상
- NEXT Oncology - Virginia, Fairfax · 11마일 거리
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
피험자 모집 중2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
피험자 모집 중1/2상
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
- Virginia Cancer Specialists, PC, Fairfax · 11마일 거리
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
피험자 모집 중2상
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
피험자 모집 중3상
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
Study of AVZO-021 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- Avenzo Therapeutics Recruiting Site, Fairfax · 11마일 거리
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
피험자 모집 중3상
- Inova Schar Cancer Institute ( Site 0025), Fairfax · 11마일 거리
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
피험자 모집 중3상
- Research Site, Fairfax · 11마일 거리
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
피험자 모집 중2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
피험자 모집 중
- Inova, Fairfax · 11마일 거리
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
피험자 모집 중3상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
피험자 모집 중2상
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
피험자 모집 중1상
- Next Virginia, Fairfax · 11마일 거리
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
피험자 모집 중1/2상
- NEXT Oncology, Fairfax · 11마일 거리
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
피험자 모집 중3상
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
피험자 모집 중1상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Oncology, Fairfax · 11마일 거리
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
피험자 모집 중1/2상
- Next Oncology, Fairfax · 11마일 거리
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
피험자 모집 중1/2상
- Virginia Cancer Specialists-Fairfax, Fairfax · 11마일 거리
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
피험자 모집 중3상
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5마일 거리
- Kaiser Permanente-Burke Medical Center, Burke · 11마일 거리
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
피험자 모집 중1상
- Inova Schar Cancer Institute, Falls Church · 4마일 거리
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
피험자 모집 중3상
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
- Inova Fair Oaks Hospital, Fairfax · 11마일 거리
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
피험자 모집 중3상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
E-Mindfulness Approaches for Living After Breast Cancer
피험자 모집 중3상
- Inova Fairfax Hospital, Falls Church · 4마일 거리
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5마일 거리
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
- 외 1개
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
피험자 모집 중1/2상
- USOR Virginia Cancer Specialists, Fairfax · 11마일 거리
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- USO-Virginia Cancer Specialists, PC, Fairfax · 11마일 거리
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
피험자 모집 중3상
- INOVA Schar Cancer, Fairfax · 11마일 거리
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
피험자 모집 중1/2상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- NEXT, Fairfax · 11마일 거리
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
피험자 모집 중1/2상
- Inova Schar Cancer Institute ( Site 0051), Fairfax · 11마일 거리
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
피험자 모집 중3상
- Virginia Cancer Specialists, PC, Reston · 14마일 거리
- Virginia Cancer Specialists, Manassas · 22마일 거리
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
피험자 모집 중1상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
피험자 모집 중1상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
피험자 모집 중1/2상
- NEXT, Virginia, Fairfax · 11마일 거리
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
피험자 모집 중1상
- Inova Schar Cancer Center, Fairfax · 11마일 거리
- NEXT Virginia, Fairfax · 11마일 거리
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
피험자 모집 중1상
- Biotheryx Investigative Site, Fairfax · 11마일 거리
다른 도시의 유방암 시험
- New York City, NY연구 136개
- Houston, TX연구 126개
- Boston, MA연구 112개
- Nashville, TN연구 81개
- Los Angeles, CA연구 73개
- Edison, NJ연구 68개
- St. Louis, MO연구 64개
- Queens, NY연구 64개
- Durham, NC연구 64개
- Chicago, IL연구 59개
- Philadelphia, PA연구 56개
- Dallas, TX연구 55개
Arlington의 다른 연구
- 비소세포폐암연구 104개
- 전이성 암연구 53개
- 대장직장암연구 52개
- 암 (전체)연구 48개
- 난소암연구 46개
- 폐암연구 41개
- 자궁내막암연구 39개
- 췌장암연구 33개
- 두경부 편평세포암연구 26개
- 소세포 폐암연구 23개
- 위암연구 20개
- 삼중음성 유방암연구 20개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.